Intelligence Platform
Patents
Browse 912 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6180110
Attenuated hepatitis a virus vaccine which grows in MRC-5 cells
expired patentUS 6169074
Peptide inhibitors of neurotransmitter secretion by neuronal cells
expired patentUS 6165745
Recombinant production of immunoglobulin-like domains in prokaryotic cells
expired patentUS 6150345
Methods for promoting survival of myelin producing cells
expired patentUS 6149904
Method for inhibiting tumor cell growth by administering to tumor cells expressing a nucle
expired patentUS 6124262
Compositions and methods for reducing adhesiveness of defective red blood cells
expired patentUS 6123941
Method for restoration of normal phenotype in cancer cells
expired patentUS 6120799
Cationic lipid compositions targeting angiogenic endothelial cells
expired patentUS 6117645
Human LH-RH receptor expression cells and use thereof
expired patentUS 6114110
Isolation and propagation of a human herpesvirus derived from AIDS-associated Kaposi's sar
expired patentUS 6096716
Liposome-mediated transfection of central nervous system cells
expired patentUS 6096534
Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of gene
expired patentUS 6096734
Photosensitizers for sensitizing cells
expired patentUS 6093557
Electrospraying apparatus and method for introducing material into cells
expired patentUS 6071509
Enhanced activation of natural killer cells using an NK cell activator and a hydrogen pero
expired patentUS 6071891
Insulin-like growth factor 1 receptors (IGF-1R) antisense oligonucleotide cells compositio
expired patentUS 6063373
Enhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scaveng
expired patentUS 6060270
Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro ki
expired patentUS 6056952
Selective elimination of T cells that recognize specific preselected targets
expired patentUS 6037125
Disruption of the mammalian RAD51 protein and disruption of proteins that associate with m
expired patentUS 6030954
Targeted delivery of poly- or oligonucleotides to cells
expired patentUS 6027888
Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic pr
expired patentUS 6017524
Inhibiting the growth p53 deficient tumor cells by administering the p53 gene
expired patentUS 6010905
Method for inducing monocytes to exhibit the phenotype of activated myeloid dendritic cell
expired